APO Research
Talk to an analyst

APO RESEARCH · REPORT

Third-party Medical Testing Services

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Third-party Medical Testing Services Market Outlook and Growth Opportunities 2026

4 June 2026196 pages

Choose your research edition.

Industry ResearchThird-party Medical Testing Services Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Third-party Medical Testing Services Industry Growth and Trends Forecast to 203286 pages · $3,450 USDMarket StructureGlobal Third-party Medical Testing Services Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032186 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Third-party Medical Testing Services Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Third-party Medical Testing Services Market Analysis and Forecast 2026-2032255 pages · $4,950 USD

Market perspective

The global Third-party Medical Testing Services market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Third-party Medical Testing Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Third-party Medical Testing Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Third-party Medical Testing Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Third-party Medical Testing Services market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Third-party Medical Testing Services market include Laboratory Corporation, KingMed Diagnostics, Daan Gene, Adicon Clinical, BGI Group, Shanghai GeneoDx Biotech, Sansure Biotech and Amoy Diagnostics, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Third-party Medical Testing Services market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Third-party Medical Testing Services and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Third-party Medical Testing Services revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Third-party Medical Testing Services market.

Third-party Medical Testing Services Segment by Company

Laboratory Corporation

KingMed Diagnostics

Daan Gene

Adicon Clinical

BGI Group

Shanghai GeneoDx Biotech

Sansure Biotech

Amoy Diagnostics

Third-party Medical Testing Services Segment by Type

General Inspection

Special Inspection

Third-party Medical Testing Services Segment by Application

Hospital

Physical Examination Center

Center for Disease Control and Prevention

Others

Third-party Medical Testing Services Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Third-party Medical Testing Services status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Third-party Medical Testing Services key companies, revenue, market share, and recent developments.

3. To split the Third-party Medical Testing Services breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Third-party Medical Testing Services market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Third-party Medical Testing Services significant trends, drivers, influence factors in global and regions.

6. To analyze Third-party Medical Testing Services competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Third-party Medical Testing Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Third-party Medical Testing Services and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Third-party Medical Testing Services.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Third-party Medical Testing Services industry.

Chapter 3: Detailed analysis of Third-party Medical Testing Services company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Third-party Medical Testing Services in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Third-party Medical Testing Services in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Third-party Medical Testing Services Industry Trends Table 2. Third-party Medical Testing Services Industry Drivers Table 3. Third-party Medical Testing Services Industry Opportunities and Challenges Table 4. Third-party Medical Testing Services Industry Restraints Table 5. Global Third-party Medical Testing Services Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Third-party Medical Testing Services Revenue Share by Company (2021-2026) Table 7. Global Third-party Medical Testing Services Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Third-party Medical Testing Services Key Company Manufacturing Base & Headquarters Table 9. Global Third-party Medical Testing Services Company, Product Type & Application Table 10. Global Third-party Medical Testing Services Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Third-party Medical Testing Services by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of General Inspection Table 15. Significant Companies of Special Inspection Table 16. Global Third-party Medical Testing Services Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Third-party Medical Testing Services Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Third-party Medical Testing Services Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Third-party Medical Testing Services Sales Value Share by Type (2021-2026) Table 20. Global Third-party Medical Testing Services Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Hospital Table 22. Significant Companies of Physical Examination Center Table 23. Significant Companies of Center for Disease Control and Prevention Table 24. Significant Companies of Others Table 25. Global Third-party Medical Testing Services Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Third-party Medical Testing Services Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global Third-party Medical Testing Services Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global Third-party Medical Testing Services Sales Value Share by Application (2021-2026) Table 29. Global Third-party Medical Testing Services Sales Value Share by Application (2027-2032) Table 30. Global Third-party Medical Testing Services Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Third-party Medical Testing Services Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global Third-party Medical Testing Services Sales Value Share by Region (2021-2026) Table 33. Global Third-party Medical Testing Services Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global Third-party Medical Testing Services Sales Value Share by Region (2027-2032) Table 35. Global Third-party Medical Testing Services Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Third-party Medical Testing Services Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global Third-party Medical Testing Services Sales Value Market Share by Country (2021-2026) Table 38. Global Third-party Medical Testing Services Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global Third-party Medical Testing Services Sales Value Market Share by Country (2027-2032) Table 40. Laboratory Corporation Company Information Table 41. Laboratory Corporation Business Overview Table 42. Laboratory Corporation Third-party Medical Testing Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. Laboratory Corporation Third-party Medical Testing Services Product Portfolio Table 44. Laboratory Corporation Recent Development Table 45. KingMed Diagnostics Company Information Table 46. KingMed Diagnostics Business Overview Table 47. KingMed Diagnostics Third-party Medical Testing Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. KingMed Diagnostics Third-party Medical Testing Services Product Portfolio Table 49. KingMed Diagnostics Recent Development Table 50. Daan Gene Company Information Table 51. Daan Gene Business Overview Table 52. Daan Gene Third-party Medical Testing Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. Daan Gene Third-party Medical Testing Services Product Portfolio Table 54. Daan Gene Recent Development Table 55. Adicon Clinical Company Information Table 56. Adicon Clinical Business Overview Table 57. Adicon Clinical Third-party Medical Testing Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. Adicon Clinical Third-party Medical Testing Services Product Portfolio Table 59. Adicon Clinical Recent Development Table 60. BGI Group Company Information Table 61. BGI Group Business Overview Table 62. BGI Group Third-party Medical Testing Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. BGI Group Third-party Medical Testing Services Product Portfolio Table 64. BGI Group Recent Development Table 65. Shanghai GeneoDx Biotech Company Information Table 66. Shanghai GeneoDx Biotech Business Overview Table 67. Shanghai GeneoDx Biotech Third-party Medical Testing Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Shanghai GeneoDx Biotech Third-party Medical Testing Services Product Portfolio Table 69. Shanghai GeneoDx Biotech Recent Development Table 70. Sansure Biotech Company Information Table 71. Sansure Biotech Business Overview Table 72. Sansure Biotech Third-party Medical Testing Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Sansure Biotech Third-party Medical Testing Services Product Portfolio Table 74. Sansure Biotech Recent Development Table 75. Amoy Diagnostics Company Information Table 76. Amoy Diagnostics Business Overview Table 77. Amoy Diagnostics Third-party Medical Testing Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Amoy Diagnostics Third-party Medical Testing Services Product Portfolio Table 79. Amoy Diagnostics Recent Development Table 80. Research Programs/Design for This Report Table 81. Authors List of This Report Table 82. Secondary Sources Table 83. Primary Sources List of Figures Figure 1. Third-party Medical Testing Services Product Image Figure 2. Global Third-party Medical Testing Services Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Third-party Medical Testing Services Market Size (2021-2032) & (US$ Million) Figure 4. Global Third-party Medical Testing Services Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. General Inspection Image Figure 8. Special Inspection Image Figure 9. Global Third-party Medical Testing Services Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Third-party Medical Testing Services Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Third-party Medical Testing Services Sales Value Share by Type (2021-2032) Figure 12. Hospital Image Figure 13. Physical Examination Center Image Figure 14. Center for Disease Control and Prevention Image Figure 15. Others Image Figure 16. Global Third-party Medical Testing Services Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Third-party Medical Testing Services Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Third-party Medical Testing Services Sales Value Share by Application (2021-2032) Figure 19. Global Third-party Medical Testing Services Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Third-party Medical Testing Services Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America Third-party Medical Testing Services Sales Value (2021-2032) & (US$ Million) Figure 22. North America Third-party Medical Testing Services Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe Third-party Medical Testing Services Sales Value (2021-2032) & (US$ Million) Figure 24. Europe Third-party Medical Testing Services Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific Third-party Medical Testing Services Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific Third-party Medical Testing Services Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America Third-party Medical Testing Services Sales Value (2021-2032) & (US$ Million) Figure 28. South America Third-party Medical Testing Services Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa Third-party Medical Testing Services Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa Third-party Medical Testing Services Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA Third-party Medical Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA Third-party Medical Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA Third-party Medical Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada Third-party Medical Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada Third-party Medical Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada Third-party Medical Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico Third-party Medical Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico Third-party Medical Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico Third-party Medical Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany Third-party Medical Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany Third-party Medical Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany Third-party Medical Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France Third-party Medical Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France Third-party Medical Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France Third-party Medical Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. Third-party Medical Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. Third-party Medical Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. Third-party Medical Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy Third-party Medical Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy Third-party Medical Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy Third-party Medical Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain Third-party Medical Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain Third-party Medical Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain Third-party Medical Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia Third-party Medical Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia Third-party Medical Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia Third-party Medical Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands Third-party Medical Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands Third-party Medical Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands Third-party Medical Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries Third-party Medical Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries Third-party Medical Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries Third-party Medical Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China Third-party Medical Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China Third-party Medical Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China Third-party Medical Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan Third-party Medical Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan Third-party Medical Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan Third-party Medical Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea Third-party Medical Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea Third-party Medical Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea Third-party Medical Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India Third-party Medical Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India Third-party Medical Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India Third-party Medical Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia Third-party Medical Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia Third-party Medical Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia Third-party Medical Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia Third-party Medical Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia Third-party Medical Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia Third-party Medical Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil Third-party Medical Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil Third-party Medical Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil Third-party Medical Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina Third-party Medical Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina Third-party Medical Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina Third-party Medical Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile Third-party Medical Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile Third-party Medical Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile Third-party Medical Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia Third-party Medical Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia Third-party Medical Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia Third-party Medical Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru Third-party Medical Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru Third-party Medical Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru Third-party Medical Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Third-party Medical Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia Third-party Medical Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Third-party Medical Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel Third-party Medical Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel Third-party Medical Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel Third-party Medical Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE Third-party Medical Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE Third-party Medical Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE Third-party Medical Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey Third-party Medical Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey Third-party Medical Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey Third-party Medical Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran Third-party Medical Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran Third-party Medical Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran Third-party Medical Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt Third-party Medical Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt Third-party Medical Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt Third-party Medical Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • General Inspection
  • Special Inspection
Applications
  • Hospital
  • Physical Examination Center
  • Center for Disease Control and Prevention
  • Others
Companies covered
  • Laboratory Corporation
  • KingMed Diagnostics
  • Daan Gene
  • Adicon Clinical
  • BGI Group
  • Shanghai GeneoDx Biotech
  • Sansure Biotech
  • Amoy Diagnostics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Third-party Medical Testing Services Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Third-party Medical Testing Services Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Third-party Medical Testing Services Market Dynamics
  1. 2.1 Third-party Medical Testing Services Industry Trends
  2. 2.2 Third-party Medical Testing Services Industry Drivers
  3. 2.3 Third-party Medical Testing Services Industry Opportunities and Challenges
  4. 2.4 Third-party Medical Testing Services Industry Restraints
3 Third-party Medical Testing Services Market by Company
  1. 3.1 Global Third-party Medical Testing Services Company Revenue Ranking in 2025
  2. 3.2 Global Third-party Medical Testing Services Revenue by Company (2021-2026)
  3. 3.3 Global Third-party Medical Testing Services Company Ranking (2024-2026)
  4. 3.4 Global Third-party Medical Testing Services Company Manufacturing Base and Headquarters
  5. 3.5 Global Third-party Medical Testing Services Company Product Type and Application
  6. 3.6 Global Third-party Medical Testing Services Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Third-party Medical Testing Services Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Third-party Medical Testing Services Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Third-party Medical Testing Services Market by Type
  1. 4.1 Third-party Medical Testing Services Type Introduction
  2. 4.1.1 General Inspection
  3. 4.1.2 Special Inspection
  4. 4.2 Global Third-party Medical Testing Services Sales Value by Type
  5. 4.2.1 Global Third-party Medical Testing Services Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Third-party Medical Testing Services Sales Value by Type (2021-2032)
  7. 4.2.3 Global Third-party Medical Testing Services Sales Value Share by Type (2021-2032)
5 Third-party Medical Testing Services Market by Application
  1. 5.1 Third-party Medical Testing Services Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Physical Examination Center
  4. 5.1.3 Center for Disease Control and Prevention
  5. 5.1.4 Others
  6. 5.2 Global Third-party Medical Testing Services Sales Value by Application
  7. 5.2.1 Global Third-party Medical Testing Services Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Third-party Medical Testing Services Sales Value by Application (2021-2032)
  9. 5.2.3 Global Third-party Medical Testing Services Sales Value Share by Application (2021-2032)
6 Third-party Medical Testing Services Regional Value Analysis
  1. 6.1 Global Third-party Medical Testing Services Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Third-party Medical Testing Services Sales Value by Region (2021-2032)
  3. 6.2.1 Global Third-party Medical Testing Services Sales Value by Region: 2021-2026
  4. 6.2.2 Global Third-party Medical Testing Services Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Third-party Medical Testing Services Sales Value (2021-2032)
  7. 6.3.2 North America Third-party Medical Testing Services Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Third-party Medical Testing Services Sales Value (2021-2032)
  10. 6.4.2 Europe Third-party Medical Testing Services Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Third-party Medical Testing Services Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Third-party Medical Testing Services Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Third-party Medical Testing Services Sales Value (2021-2032)
  16. 6.6.2 South America Third-party Medical Testing Services Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Third-party Medical Testing Services Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Third-party Medical Testing Services Sales Value Share by Country, 2025 VS 2032
7 Third-party Medical Testing Services Country-level Value Analysis
  1. 7.1 Global Third-party Medical Testing Services Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Third-party Medical Testing Services Sales Value by Country (2021-2032)
  3. 7.2.1 Global Third-party Medical Testing Services Sales Value by Country (2021-2026)
  4. 7.2.2 Global Third-party Medical Testing Services Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Third-party Medical Testing Services Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Third-party Medical Testing Services Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Third-party Medical Testing Services Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Third-party Medical Testing Services Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Third-party Medical Testing Services Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Third-party Medical Testing Services Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Third-party Medical Testing Services Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Third-party Medical Testing Services Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Third-party Medical Testing Services Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Third-party Medical Testing Services Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Third-party Medical Testing Services Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Third-party Medical Testing Services Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Third-party Medical Testing Services Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Third-party Medical Testing Services Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Third-party Medical Testing Services Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Third-party Medical Testing Services Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Third-party Medical Testing Services Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Third-party Medical Testing Services Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Third-party Medical Testing Services Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Third-party Medical Testing Services Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Third-party Medical Testing Services Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Third-party Medical Testing Services Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Third-party Medical Testing Services Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Third-party Medical Testing Services Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Third-party Medical Testing Services Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Third-party Medical Testing Services Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Third-party Medical Testing Services Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Third-party Medical Testing Services Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Third-party Medical Testing Services Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Third-party Medical Testing Services Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Third-party Medical Testing Services Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Third-party Medical Testing Services Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Third-party Medical Testing Services Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Third-party Medical Testing Services Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Third-party Medical Testing Services Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Third-party Medical Testing Services Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Third-party Medical Testing Services Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Third-party Medical Testing Services Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Third-party Medical Testing Services Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Third-party Medical Testing Services Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Third-party Medical Testing Services Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Third-party Medical Testing Services Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Third-party Medical Testing Services Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Third-party Medical Testing Services Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Third-party Medical Testing Services Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Third-party Medical Testing Services Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Third-party Medical Testing Services Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Third-party Medical Testing Services Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Third-party Medical Testing Services Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Third-party Medical Testing Services Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Third-party Medical Testing Services Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Third-party Medical Testing Services Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Third-party Medical Testing Services Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Third-party Medical Testing Services Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Third-party Medical Testing Services Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Third-party Medical Testing Services Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Third-party Medical Testing Services Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Third-party Medical Testing Services Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Third-party Medical Testing Services Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Third-party Medical Testing Services Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Third-party Medical Testing Services Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Third-party Medical Testing Services Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Third-party Medical Testing Services Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Third-party Medical Testing Services Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Third-party Medical Testing Services Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Third-party Medical Testing Services Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Third-party Medical Testing Services Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Third-party Medical Testing Services Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Third-party Medical Testing Services Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Third-party Medical Testing Services Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Third-party Medical Testing Services Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Third-party Medical Testing Services Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Third-party Medical Testing Services Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Third-party Medical Testing Services Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Third-party Medical Testing Services Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Third-party Medical Testing Services Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Third-party Medical Testing Services Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Third-party Medical Testing Services Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Third-party Medical Testing Services Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Third-party Medical Testing Services Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Third-party Medical Testing Services Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Third-party Medical Testing Services Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Third-party Medical Testing Services Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Third-party Medical Testing Services Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Laboratory Corporation
  2. 8.1.1 Laboratory Corporation Company Information
  3. 8.1.2 Laboratory Corporation Business Overview
  4. 8.1.3 Laboratory Corporation Third-party Medical Testing Services Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Laboratory Corporation Third-party Medical Testing Services Product Portfolio
  6. 8.1.5 Laboratory Corporation Recent Developments
  7. 8.2 KingMed Diagnostics
  8. 8.2.1 KingMed Diagnostics Company Information
  9. 8.2.2 KingMed Diagnostics Business Overview
  10. 8.2.3 KingMed Diagnostics Third-party Medical Testing Services Revenue and Gross Margin (2021-2026)
  11. 8.2.4 KingMed Diagnostics Third-party Medical Testing Services Product Portfolio
  12. 8.2.5 KingMed Diagnostics Recent Developments
  13. 8.3 Daan Gene
  14. 8.3.1 Daan Gene Company Information
  15. 8.3.2 Daan Gene Business Overview
  16. 8.3.3 Daan Gene Third-party Medical Testing Services Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Daan Gene Third-party Medical Testing Services Product Portfolio
  18. 8.3.5 Daan Gene Recent Developments
  19. 8.4 Adicon Clinical
  20. 8.4.1 Adicon Clinical Company Information
  21. 8.4.2 Adicon Clinical Business Overview
  22. 8.4.3 Adicon Clinical Third-party Medical Testing Services Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Adicon Clinical Third-party Medical Testing Services Product Portfolio
  24. 8.4.5 Adicon Clinical Recent Developments
  25. 8.5 BGI Group
  26. 8.5.1 BGI Group Company Information
  27. 8.5.2 BGI Group Business Overview
  28. 8.5.3 BGI Group Third-party Medical Testing Services Revenue and Gross Margin (2021-2026)
  29. 8.5.4 BGI Group Third-party Medical Testing Services Product Portfolio
  30. 8.5.5 BGI Group Recent Developments
  31. 8.6 Shanghai GeneoDx Biotech
  32. 8.6.1 Shanghai GeneoDx Biotech Company Information
  33. 8.6.2 Shanghai GeneoDx Biotech Business Overview
  34. 8.6.3 Shanghai GeneoDx Biotech Third-party Medical Testing Services Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Shanghai GeneoDx Biotech Third-party Medical Testing Services Product Portfolio
  36. 8.6.5 Shanghai GeneoDx Biotech Recent Developments
  37. 8.7 Sansure Biotech
  38. 8.7.1 Sansure Biotech Company Information
  39. 8.7.2 Sansure Biotech Business Overview
  40. 8.7.3 Sansure Biotech Third-party Medical Testing Services Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Sansure Biotech Third-party Medical Testing Services Product Portfolio
  42. 8.7.5 Sansure Biotech Recent Developments
  43. 8.8 Amoy Diagnostics
  44. 8.8.1 Amoy Diagnostics Company Information
  45. 8.8.2 Amoy Diagnostics Business Overview
  46. 8.8.3 Amoy Diagnostics Third-party Medical Testing Services Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Amoy Diagnostics Third-party Medical Testing Services Product Portfolio
  48. 8.8.5 Amoy Diagnostics Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst